Skip to main content

Month: May 2021

Verano Announces Filing of Preliminary Base Shelf Prospectus

CHICAGO, May 14, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE:VRNO) (OTCQX:VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced it has filed a preliminary short form base shelf prospectus with the securities regulators in all of the provinces and territories of Canada. When made final or effective, this filing will allow the Company to make offerings from time to time of, among other securities of the Company, Class A subordinate voting shares of the Company, Class B proportionate voting shares of the Company, warrants to purchase securities of the Company, subscription receipts and debt securities of the Company of up to C$1,254,450,000 during the 25-month period that the base shelf prospectus is effective. The specific terms of any offering of securities issued under the base shelf...

Continue reading

Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

        – First Patient Dosed in Phase 1 AL102 Combination Trial with Novartis’ Anti-BCMA Agent for the Treatment of Multiple Myeloma – – On Track to Initiate AL102 Phase 2/3 Pivotal Trial for the Treatment of Desmoid Tumors in 1H21- – Multiple Near-Term Milestones Expected Across Clinical-Stage Pipeline – REHOVOT, Israel and WILMINGTON, Del., May 14, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today reported financial results for the first quarter ended March 31, 2021 and highlighted recent progress and upcoming milestones for its pipeline programs. “Continuing...

Continue reading

J & J Snack Foods Appoints DAN FACHNER CHIEF EXECUTIVE OFFICER

Company Founder Gerald B. Shreiber To Remain Chairman of the Board PENNSAUKEN, N.J., May 14, 2021 (GLOBE NEWSWIRE) — J & J Snack Foods Corp. (NASDAQ: JJSF) today announced the appointment of Dan Fachner as Chief Executive Officer, effective May 11, 2021. Mr. Fachner currently serves as President, a role he assumed in May 2020 after a notable tenure with the company. Gerald “Gerry” B. Shreiber, will remain Chairman of the Board. “Through the discipline, leadership and vision of Gerry Shreiber, J & J Snack Foods transformed from a small local soft pretzel bakery to the multifaceted billion-dollar public company it is today,” said Mr. Fachner. “Gerry’s imprint on our employees, customers, consumers and shareholders is indelible, and his story remains one of the most captivating and inspiring in American business. It is a...

Continue reading

AYRO to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021

AUSTIN, May 14, 2021 (GLOBE NEWSWIRE) — AYRO, Inc. (Nasdaq: AYRO) a designer and manufacturer of light-duty, short-haul, and last-mile delivery electric vehicles (EVs), today announced that management will participate at the Investor Summit Conference on May 17, 2021. Chief Executive Officer Rod Keller will deliver his corporate presentation at 3:30pm ET on May 17, 2021. Investors can also request a one-on-one meeting with Mr. Keller to be arranged following the conclusion of the conference. Investors can register for the conference here. About AYRO, Inc. Texas-based AYRO, Inc., engineers and manufactures purpose-built electric vehicles to enable sustainable fleets. With rapid, customizable deployments that meet specific buyer needs, AYRO’s agile EVs are an eco-friendly microdistribution alternative to gasoline vehicles. The AYRO...

Continue reading

Vasta Announces First Quarter 2021 Results

InfographicNet revenue breakdown among business lines in the commercial cycle to date, 2021 vs. 2020 (R$ million)SÃO PAULO, Brazil, May 14, 2021 (GLOBE NEWSWIRE) — Vasta Platform Limited (NASDAQ: VSTA) – “Vasta” or the “Company,” announces today its financial and operating results for the first quarter of 2021 (4Q21) ended March 31, 2021. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). HIGHLIGHTSRevenue from subscription products ex-PAR jumped 20% in the 4Q20 and 1Q21 combined (2021 commercial year to date), in comparison to the same period of last year. This increase is slightly below the 23% growth in ACV, owing to the lower number of students at partner schools due to the Covid-19 effects. The PAR learning system,...

Continue reading

ISW Holdings Announces Board Approval for Initiation of Quarter-Million-Dollar Stock Buyback Program

LAS VEGAS, NV, May 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company with commercial operations in Telehealth and Cryptocurrency Mining, is pleased to announce that the Company’s Board of Directors has officially approved a significant share buyback program for immediate activation. The size of the Buyback program has been initially set at up to $250k, but may be expanded in the future. “We have substantial cash reserves, strong growth expectations, and expanding productive resources targeting rapidly growing end markets, as well as an absolute commitment to delivering shareholder value over the long term,” stated Alonzo Pierce, President and Chairman of ISW Holdings. Management notes the Company has strengthened its...

Continue reading

Outlook Therapeutics Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Corporate Update

Topline efficacy and safety data from pivotal Phase 3 NORSE TWO study on target to report in calendar Q3 2021Recently reported topline data from the NORSE THREE open-label safety study reinforce positive safety profile of ONS-5010 seen in the earlier clinical experience trial (NORSE ONE)ISELIN, N.J., May 14, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced recent corporate highlights and financial results for its fiscal second quarter ended March 31, 2021. Outlook Therapeutics also provided a clinical development and pre-commercialization update on ONS-5010 / LYTENAVA™ (bevacizumab-vikg), its investigational ophthalmic formulation of...

Continue reading

Bel Announces Investor Conference (Virtual) Schedule for May and June 2021

16th Annual Needham Virtual Technology & Media Conference, May 20, 2021 Stifel Cross Sector Insight Conference, June 9, 2021 JERSEY CITY, N.J., May 14, 2021 (GLOBE NEWSWIRE) — Bel Fuse Inc. (“Bel,” or, “the Company”) (Nasdaq:BELFA and Nasdaq:BELFB), a leading supplier of products that power, protect and connect electronic circuits, today announced that management will participate in two upcoming investor conferences that are being held virtually, the 16th Annual Needham Virtual Technology & Media Conference and the Stifel Cross Sector Insight Conference. Senior management from Bel will be available to meet virtually with investors in one-on-one sessions at each of these conferences, and interested parties may schedule a one-on-one meeting in advance of the conference through the respective hosts’ on-line meeting platforms,...

Continue reading

Acme United Corporation to Present at the Sidoti Microcap Virtual Conference

SHELTON, Conn., May 14, 2021 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) will present at the Sidoti Microcap Virtual Conference on Wednesday, May 19, 2021 at 11:30am EDT. Acme United’s Chairman and Chief Executive Officer Walter Johnsen will also meet one-on-one with institutional investors on Wednesday, May 19th. A webcast of Acme United’s presentation and supporting material will be available in the Investor Relations section of the company’s website at: https://acmeunited.gcs-web.com/. To obtain additional information about Acme United’s participation in the Sidoti Spring 2021 Virtual Conference please contact Sidoti & Company. About Acme United ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting...

Continue reading

Identity & Access Management Solutions Provider BIO-key’s Q1 Revenues Improved to $1.9M versus $0.5M in Q1’20 and $1.1M in Q4; Investor Call Today at 10am ET

WALL, N.J., May 14, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and multi-factor identity and access management (IAM) solutions for strong, convenient user authentication and large-scale identity applications, today reported results for its first quarter ended March 31, 2021 (Q1’21). BIO-key will host a conference call today at 10:00 a.m. ET (details below) to review its results and outlook. Q1 & Recent Highlights:BIO-key began initial technology deployments for its large-scale ID projects in Africa, recording hardware revenue of $680k in Q1. BIO-key secured a $1.2M, three-year contract extension from a Fortune 500 telecommunications customer for fingerprint biometric security support services.   BIO-key added new higher education customer contracts in the quarter,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.